Evaluación de la irritabilidad en mucosa del adyuvante AFCO1 por el método de HET-CAM

Batista, Alexander; Murillo, Gisela; Pérez, Ulpiano; Tur, Enieyis; Portuondo, Deivys; Pérez, Oliver
January 2011
Revista VacciMonitor (Vacunología y Temas Afines);ene-abr2011, Vol. 20 Issue 1, p22
Academic Journal
No abstract available.


Related Articles

  • New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity. Tamargo, Beatriz; Márquez, Yanet; Ramírez, Wendy; Cedré, Bárbara; Fresno, Manuel; Sierra, Gustavo // BMC Immunology;2013, Vol. 14 Issue Suppl 1, p1 

    Proteoliposomes purified from the Outer Membrane of Neisseria meningitidis B, have been successfully used as core for adjuvants and vaccine formulations. We have tried to increase their structural definition and to conserve their efficacy and stability avoiding the addition of the aluminum...

  • Mucosal immune response induced by proteoliposome and cochleate derived from serogroups B N. meningitidis. Del Campo, Judith; Lastre, Miriam; Zayas, Caridad; Acevedo, Reinaldo; González, Elizabeth; Romeu, Belkis; Cuello, Maribel; Cabrera, Osmir; Balboa, Julio; Sarandi, Ali M.; Pérez, Oliver // Revista VacciMonitor (Vacunología y Temas Afines);May-Aug2009, Vol. 18 Issue 2, p69 

    Mucosal vaccination offers attractive advantages to conventional systemic vaccination. Most pathogens enter or establish infection at mucosal surfaces. This represents an enormous challenge for vaccine development. Nevertheless, the availability of safe and effective adjuvants that function...

  • Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus. Lazo, Laura; Gil, Lázaro; Lopez, Carlos; Valdes, Iris; Marcos, Ernesto; Álvarez, Mayling; Blanco, Aracelys; Romero, Yaremis; Falcon, Viviana; Guzmán, María G.; Guillén, Gerardo; Hermida, Lisset // Archives of Virology;Oct2010, Vol. 155 Issue 10, p1587 

    In this study, we evaluate in mice a novel formulation containing nucleocapsid-like particles of dengue-2 virus (recNLP) co-immunized with a chimeric protein composed of the dengue-4 envelope domain III fused twice within the meningococcal P64k protein of Neisseria meningitidis (PD24). The...

  • Mucosal and systemic immune response against Neisseria meningitidis b induced by single time vaccination strategy. González, E.; Romeu, B.; Del Campo, J.; Acevedo, R.; Lastre, M.; Zayas, C.; Cuello, M.; Cabrera, O.; Balboa, J.; Nuñez, N.; Valdez, Y.; Fariñas, M.; Pérez, O. // Revista VacciMonitor (Vacunología y Temas Afines);May-Aug2009, Vol. 18 Issue 2, p73 

    Immunization is one of the most successful and cost-effective health interventions ever. Immunization have been helping to reduce child mortality, improving maternal health and combating infectious diseases. In spite of its, undisputed past success and promising future, however, immunization...

  • The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi. Molyneux E M; Tembo M; Kayira K; Bwanaisa L; Mweneychanya J; Njobvu A; Forsyth H; Rogerson S; Walsh A L; Molyneux M E // Archives of Disease in Childhood;Dec2003, Vol. 88 Issue 12, p1112 

    AIM: To compare presentation, progress, and outcome of acute bacterial meningitis in HIV seropositive and seronegative children. METHODS: A double blind randomised placebo controlled study of the use of dexamethasone as adjuvant therapy in acute bacterial meningitis, in children aged 2 months to...

  • Modulation of Immune Response to Group C Meningococcal Conjugate Vaccine Given Intranasally to Mice Together with the LTK63 Mucosal Adjuvant and the Trimethyl Chitosan Delivery System. Baudner, Barbara C.; Morandi, Maurizio; Giuliani, Marzia M.; J. Coos Verhoef; Junginger, Hans E.; Costantino, Paolo; Rappuoli, Rino; Del Giudice, Giuseppe // Journal of Infectious Diseases;3/1/2004, Vol. 189 Issue 5, p828 

    Previous work had shown that the immunogenicity of conjugate vaccine against group C meningococci (CRM-MenC) is enhanced when it is delivered intranasally (inl) with mucosal adjuvants, such as mutants of the Escherichia coli enterotoxin (LT), and with delivery systems such as chitosan ...

  • Active Immunization with a Detoxified Endotoxin Vaccine Protects against Lethal Polymicrobial Sepsis: Its Use with CpG Adjuvant and Potential Mechanisms. Opal, Steven M.; Palardy, John E.; Chen, Wilbur H.; Parejo, Nicolas A.; Bhattacharjee, Apurba K.; Cross, Alan S. // Journal of Infectious Diseases;12/15/2005, Vol. 192 Issue 12, p2074 

    Background. An experimental vaccine for sepsis, composed of detoxified Escherichia coli J5 lipopolysaccharide (LPS) complexed with the outer membrane protein (OMP) of Neisseria meningitidis group B, induces anti-core glycolipid antibody and has been tested in pilot studies in human volunteers....

  • Mucosal adjuvanticity of immunostimulatory DNA sequences. Horner, Anthony A.; Cinman, Nadya; Ronaghy, Arash; Raz, Eyal // Springer Seminars in Immunopathology;2000, Vol. 22 Issue 1/2, p133 

    Studies the mucosal adjuvanticity of immunostimulatory DNA sequences. Activation of the mucosal immune system; Induction of antibody response; Mucosal delivery of replicating immunogens.

  • Mucosal Adjuvants. Harandi, Ali M.; Medaglini, Donata // Current HIV Research;Jun2010, Vol. 8 Issue 4, p330 

    The vast majority of pathogens invade the body through or establish infections in the mucosal tissues. Development of vaccines to combat mucosal infections represents a top priority. Mucosal immunization has recently attracted much interest as a means of generating protective immunity against...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics